For condition: Atopic Dermatitis
For condition: Eczema – Atopic Dermatitis
Adult’s Atopic Dermatitis Study (62 Weeks)
Study Summary
Who Can Participate?
Male or Female aged 18 and above with moderate to severe atopic dermatitis (eczema) may participate.
Inclusion Criteria
- Chronic atopic dermatitis (AD) that has been present for at least an year
- Body surface area of 10% or more affected by AD
- Documented recent history of inadequate response to treatment with topical medications, or study participants for whom topical treatments are otherwise medically inadvisable (eg, due to important side effects or safety risks) and who are candidates for systemic therapy
Participant Information
- Participate and receive study treatment at no cost
- Regular visits with study doctors who specialise in treating AD (29 visits)
- Will receive either an investigative subcutaneous treatment (study drug) or a placebo
- Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
- Up to approximately 62 weeks
For more information about this trial, please visit ClinicalTrials.gov
